Percheron Therapeutics LimitedASX: PER

Phase II clinical trial in DMD Update

Apr 4, 2019 at 3:13 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment